Hendrianus The: Intravenous Cangrelor in Hemodynamically Unstable Patients Undergoing PCI
Hendrianus The, Interventional & Structural Cardiology Fellow at Heart and Brain Hospital, Chung-Ang University Medical Center, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I would like to share our recently published meta-analysis evaluating intravenous cangrelor in hemodynamically unstable patients undergoing PCI.
We found that IV cangrelor was associated with reduced mortality, with the most pronounced benefit observed in patients with cardiogenic shock, along with improved coronary flow.
These findings support its role as a valuable alternative when oral P2Y12 inhibitor administration is not feasible, pending confirmation in large-scale randomized trials.”
Title: Cangrelor in critically ill patients with cardiogenic shock or post-cardiac arrest undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Authors: Hendrianus Hendrianus, Young-Hoon Jeong, Sang Yeub Lee, Jun Hwan Cho, Jinhwan Jo, Diana A. Gorog, Jacek Kubica, Udaya S. Tantry, Paul A. Gurbel, Sang-Wook Kim
Read the Full Article on Critical Care
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction
-
Jul 9, 2026, 08:46Jordan Agay: Folate Deficiency in Patients Receiving PARP Inhibitors
-
Jul 9, 2026, 08:29Laura Katz: Is Human Lactoferrin Better Than Bovine Lactoferrin?
-
Jul 9, 2026, 08:17Anziya Sabeer: AI-Driven Non-Invasive Anemia Detection
-
Jul 9, 2026, 07:37Variable Mechanisms of ADAMTS13 Inhibition by Autoantibodies in iTTP – JTH
-
Jul 9, 2026, 07:31DHR-Sponsored Training Programme at ICMR-CRMCH Week 2 – Day 4 – ICMR-NIRBID
-
Jul 9, 2026, 06:03Barbara Adams Krolak: ISTH Launches Global Women’s Health Hub
-
Jul 9, 2026, 05:49Abdul Mannan: A Low Platelet Count is not Always a Bone Marrow Problem